Galena Biopharma - Zuplenz's Unit Acquisition

Galena Biopharma - Zuplenz raised a round of funding on December 18, 2015. Investors include Midatech Pharma.

Galena Biopharma (Nasdaq: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of ca…

Articles about Galena Biopharma - Zuplenz's Unit Acquisition: